Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
RFS designed to reduce burden for drug manufacturers to prep packaging components for sterilization.
October 17, 2023
By: Anthony Vecchione
Datwyler, a provider of high-quality, system-critical elastomer components, launched its ready-for-sterilization (RFS) combiseals for cartridges used in injection devices such as pens and autoinjectors. As combiseals are in direct contact with the drugs administered, they are required to be clean enough to comply with regulatory requirements and prevent any risk to patients. The pharmaceutical companies receive a product with a controlled state of microbiological cleanliness, as the combiseals are furthermore packed in an environment with a defined and controlled state of cleanliness, complying with FDA and EU requirements. Prior to arriving at the sterile drug manufacturer, the RFS combiseals undergo Datwyler’s own Water-for-Injection washing process and are packed in steam sterilizable (RFS) bags to ensure a controlled state of microbiological cleanliness that complies with FDA and EU requirements. This enables immediate sterilization of the combiseals. The 100% camera inspection and regulatory compliant washing program provides fewer visual defects, and fewer rejects on their production lines. The washing validation information process will be filed in Datwyler’s DMF so that customers can reference the same for drug submissions to the FDA by using RFS combiseals. The company also began working on another advancement, ready-to-use (RTU) combiseals to further minimize the work of drug manufacturers. The service, projected to be introduced to Datwyler’s portfolio in 2024, will handle both washing and sterilization steps in the production process. “In general, there is a trend that pharma companies want to focus mainly on their core activities – drug manufacturing,” said Carina Van Eester, global platform leader, prefilled syringes, and cartridges, at Datwyler. “Washing and sterilization of rubber materials is more and more done by the rubber manufacturers. Combiseals are the final product in our portfolio to supply in RFS format. Bringing value for our customers has always been a guiding force behind Datwyler’s overall philosophy. Our RFS combiseal offering is a natural result of that philosophy and Datwyler’s devotion to serving its customers’ needs.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !